Themis Medicare share price today

Themis Medicare Ltd's share price was ₹99.52 at the close on 4 November 2026. It has been rising for 16 weeks. That is 9.4% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹70 and ₹128, and at that close it sat 51% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Themis Medicare Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 3 weeks running.

Over the last 11 years the share price moved +257% while the NIFTY 500 moved +257%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 16 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Two changes stood out: lowest operating margin in 15 quarters and highest quarterly profit in 8 quarters.

1. Lowest operating margin in 15 quarters

   Operating margin was -60% in the June 2026 quarter, against -10% a year earlier.

2. Highest quarterly profit in 8 quarters

   Profit of ₹25 crore in the June 2026 quarter is the highest of the last 8 quarters.

For April to June 2026 (the quarter ended 30 June 2026), Themis Medicare reported revenue of ₹87.0 crore, down 11.2% from ₹98.0 crore a year earlier, and a profit of ₹25.0 crore, against a loss of ₹14.0 crore a year earlier.

Themis Medicare results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Themis Medicare closed at ₹99.52 on 4 November 2026, down 14.3% from ₹116.15 a year earlier (7 November 2025) and up 6.4% over five years. Its highest weekly close since February 2016 was ₹293.05 on 6 December 2024.

Themis Medicare share price: then and now

Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

564 weekly closes from 26 February 2016 to 4 November 2026.

4 Nov 2026: Themis Medicare closed at ₹99.52, up 4.8% on the week and down 12.8% on the month. 23 Sep 2026: ex-date for a dividend of ₹0.50 a share.

Earlier

• Results for April to June 2026: Revenue down 11.2% on a year earlier.

Themis Medicare paid ₹0.50 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.50% at the ₹99.52 close on 4 November 2026. The last was a dividend of ₹0.50 a share, ex-date 23 September 2026.

Themis Medicare dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date.

Yes. Themis Medicare Ltd paid out 404% of its profit as dividends in FY26, and it paid a dividend in 10 of its last 13 reported years.

From the NSE corporate-actions record, read 5 November 2026.

Themis Medicare is on 2 of our India lists: Penny stocks and Pharma stocks.

Themis Medicare Ltd earned ₹25.0 Cr of net profit in the Jun 2026 quarter. Full-year FY26 profit was ₹1.0 Cr. Over 10 years profit has grown −24.2% a year on average. That is 28.7% of the quarter's revenue. The same quarter a year earlier lost ₹14.0 Cr. 3 of the last 12 reported quarters were loss-making.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹1.0 Cr (−96.7% on the year before).

Themis Medicare Ltd reported ₹87.0 Cr of revenue in the Jun 2026 quarter, −11.2% on the same quarter a year earlier. Over 10 years it has grown 4.0% a year on average. The last full year, FY26, came in at ₹342 Cr. The last four reported quarters add to ₹332 Cr.

Revenue is everything the company billed its customers in the period.

FY26 revenue was ₹342 Cr, −15.8% on the year before.

Recent pace: the last four quarters grew −10.5% on average, against 4.0% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew −12.9%, against −9.9% a year over the last 8 quarters (stabilising).

Themis Medicare Ltd's operating margin was −60.0% in the Jun 2026 quarter, 50.0 percentage points lower than the same quarter a year ago. Across 13 years it has been between 0.1% and 24.0%. The latest quarter is below every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −49.8 percentage points on the year while gross margin changed −13.0 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

Over the last 3 years, 72% of Themis Medicare Ltd's reported profit came in as cash from its operations, so most of the profit is real cash. In FY26 its operations used ₹3.0 Cr of cash, against ₹1.0 Cr of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

After ₹4.0 Cr of spending on assets, free cash was −₹7.0 Cr: it spent more than its operations brought in.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 72% of profit came in as cash: the cash cycle got 24 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives.

What to look at next: less of the profit turns into cash than it should, and the cash cycle is 24 days longer. The next section looks at where the cash is stuck.

Themis Medicare Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 275 days in FY26, up from 251 days in FY21. It spent ₹36.0 Cr on assets over the last 3 years. Customers take 190 days to pay, and stock sits for 229 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹342 Cr, each day of that cycle ties up about ₹0.9 Cr, so roughly ₹258 Cr is tied up in the business at any time.

FY26: customers took 190 days to pay and stock sat for 229 days, about 7.5 months of sales sitting as stock, for a full cycle of 275 days, longer than FY21's 251.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 229 days. Customers pay about 190 days after that. Suppliers are paid at 143 days. Together that makes the 275-day cycle.

Spending on assets: ₹36.0 Cr over the last 3 years, against ₹32.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹2.0 Cr (FY26): assets paid for that are not earning yet.

In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit.

Themis Medicare Ltd's P/E is 36.1×, near the high end of its own history: higher than 72% of past readings. Its usual P/E (the middle reading) is 25.6×, over 9.4 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.